feed,title,long_url,short_url
Benzinga,Pulmatrix Stock Is Trading Lower After JNJ's Lung Cancer Initiative Terminates PUR1800 Licensing Pact,https://benzinga.com/general/biotech/21/04/20582484/pulmatrix-stock-is-trading-lower-after-jnjs-lung-cancer-initiative-terminates-pur1800-licensing-p,https://j.mp/3seLSUC
